These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22935796)

  • 1. Mark McClellan. Interview by Asher Mullard.
    McClellan M
    Nat Rev Drug Discov; 2012 Sep; 11(9):668. PubMed ID: 22935796
    [No Abstract]   [Full Text] [Related]  

  • 2. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 3. Michael Snyder. Interview by Asher Mullard.
    Snyder M
    Nat Rev Drug Discov; 2012 Oct; 11(10):744. PubMed ID: 23023673
    [No Abstract]   [Full Text] [Related]  

  • 4. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 5. Mark Fishman. Interview by Asher Mullard.
    Fishman M
    Nat Rev Drug Discov; 2012 Jan; 11(1):14-5. PubMed ID: 22212670
    [No Abstract]   [Full Text] [Related]  

  • 6. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 7. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 8. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

  • 9. The changing landscape of US drug discovery research.
    Desai MC; Chackalamannil S
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):376-8. PubMed ID: 20608290
    [No Abstract]   [Full Text] [Related]  

  • 10. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 11. Gigi Hirsch. Interview by Asher Mullard.
    Hirsch G
    Nat Rev Drug Discov; 2014 Jan; 13(1):14. PubMed ID: 24378793
    [No Abstract]   [Full Text] [Related]  

  • 12. Trevor Mundel. Interview by Asher Mullard.
    Nat Rev Drug Discov; 2012 Mar; 11(4):264-5. PubMed ID: 22460116
    [No Abstract]   [Full Text] [Related]  

  • 13. Stephen Frye. Interview by Asher Mullard.
    Frye S
    Nat Rev Drug Discov; 2012 Apr; 11(5):346. PubMed ID: 22495334
    [No Abstract]   [Full Text] [Related]  

  • 14. Paul Stoffels. Interview by Asher Mullard.
    Stoffels P
    Nat Rev Drug Discov; 2013 Apr; 12(4):258. PubMed ID: 23535929
    [No Abstract]   [Full Text] [Related]  

  • 15. RuiPing Dong. Interview by Asher Mullard.
    Dong R
    Nat Rev Drug Discov; 2012 Feb; 11(2):100. PubMed ID: 22293559
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 17. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 18. Can medicine serve both humanity and the bottom line?
    Clough JD
    Cleve Clin J Med; 1996 Sep; 63(5):257-8. PubMed ID: 8870333
    [No Abstract]   [Full Text] [Related]  

  • 19. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonprofit foundations spur translational research.
    Zaratin P; Battaglia MA; Abbracchio MP
    Trends Pharmacol Sci; 2014 Nov; 35(11):552-5. PubMed ID: 25441773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.